SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-011799 to Yuanbao Inc. (YB)

Yuanbao Inc.
Date: Oct. 22, 2024 · CIK: 0001995520 · Accession: 0000000000-24-011799

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-282164

Date
October 21, 2024
Author
Office of Finance
Form
UPLOAD
Company
Yuanbao Inc.

Letter

October 21, 2024 Rui Fang Chief Executive Officer Yuanbao Inc. Building 2 No. 8 Beichen West Road Chaoyang District, Beijing, 100101 The People's Republic of China Re:Yuanbao Inc. Registration Statement on Form F-1 Filed September 16, 2024 File No. 333-282164 Dear Rui Fang: We have reviewed your registration statement and have the following comments. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. Form F-1 filed September 16, 2024 General 1.In light of the six-month suspension of your auditor, PricewaterhouseCoopers Zhong Tian LLP ("PwC China"), by applicable Chinese authorities , please tell us how it may impact your filing and your plans moving forward in light of any developments, including whether the company is planning to continue using the audited financial statements and consent currently included in the registration statement, or what alternative plans are being made. For example, it is unclear what alternative plans are being considered and whether they may require authorization by the CSRC. Please continue to update us as applicable.

October 21, 2024 Page 2 Risk Factors, page 29 2.We note your disclosure on page 46 related to risks stemming from service providers that may be subject to regulatory penalties or suspension or found in violation of any applicable rules and regulations. Please add a separately captioned risk factor discussing the fact that China's finance ministry and securities regulator recently imposed a six-month suspension on your auditor, PricewaterhouseCoopers Zhong Tian LLP ("PwC China"). In addition, clarify and discuss the scope of the suspension, including: •the specific dates of the suspension; •if the suspension impacts your ability to consult with the auditor during the six- month period; •if the suspension is expected to have any impact on your ability to make timely Exchange Act filings that require audits, such as your next 20-F; •whether the suspension is limited to PwC China or also impacts PricewaterhouseCoopers LLP, the firm listed on the consent filed as exhibit 23.1, or other affiliated entities, such as PwC Hong Kong; •whether there is a possibility the duration of the suspension could be extended beyond six-months or additional suspensions could be imposed on your auditor or its affiliate entities, and •other potential consequences of the suspension that are reasonably likely to have a material, adverse impact on you. Description of Share Capital, page 202 3.We note that you removed disclosure related to an exclusive forum provision from this section, while retaining bracketed disclosure about the risks stemming from the deposit agreement, including an exclusive forum provision beginning on page 86. Please provide disclosure about any exclusive forum provisions in your governing documents here or in another appropriate section. Please ensure that such disclosure clarifies whether the provision applies to actions arising under the Securities Act or Exchange Act. If so, please also state that there is uncertainty as to whether a court would enforce such provision. If the provision applies to Securities Act claims, please also state that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. In that regard, we note that Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. If this provision does not apply to actions arising under the Securities Act or Exchange Act, please also ensure that the exclusive forum provision in the governing documents states this clearly, or tell us how you will inform investors in future filings that the provision does not apply to any actions arising under the Securities Act or Exchange Act. Experts, page 246 We note the recent six-month business suspension imposed on your auditor, PricewaterhouseCoopers Zhong Tian LLP, by the Ministry of Finance in China. 4.

October 21, 2024 Page 3 Please provide us with an analysis explaining how this suspension impacts your auditor’s ability to provide an updated consent signed by PricewaterhouseCoopers Zhong Tian LLP or their ability to perform any other auditor-related work in connection with this registration statement during the period of suspension. Exhibit Index Exhibit 23.1, page II-4 5.We note your disclosure on page 246 that the financial statements included in the Prospectus have been so included in reliance on the report of PricewaterhouseCoopers Zhong Tian LLP, an independent registered public accounting firm, given the authority of said firm as experts in auditing and accounting. We also note that the audit report on page F-2 is signed by PricewaterhouseCoopers Zhong Tian LLP and that the exhibit index on page II-4 indicates the consent is provided by this same accounting firm. However, the consent filed as exhibit 23.1 is signed by PricewaterhouseCoopers LLP. Please explain the relationship between these two entities and how you determined it was appropriate for PricewaterhouseCoopers LLP to consent to a report that was issued by PricewaterhouseCoopers Zhong Tian LLP. 6.We note that the consent filed as exhibit 23.1 is signed by PricewaterhouseCoopers LLP located in Beijing, the People’s Republic of China. According to the PCAOB’s list of registered accounting firms, we were unable to identify a firm with this name at this location. Please explain this apparent inconsistency and revise as necessary. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement. Please contact Ben Phippen at 202-551-3697 or Marc Thomas at 202-551-3452 if you have questions regarding comments on the financial statements and related matters. Please contact John Stickel at 202-551-3324 or Susan Block at 202-551-3210 with any other questions. Sincerely, Division of Corporation Finance Office of Finance

Show Raw Text
October 21, 2024
Rui Fang
Chief Executive Officer
Yuanbao Inc.
Building 2 No. 8 Beichen West Road
Chaoyang District, Beijing, 100101
The People's Republic of China
Re:Yuanbao Inc.
Registration Statement on Form F-1
Filed September 16, 2024
File No. 333-282164
Dear Rui Fang:
            We have reviewed your registration statement and have the following comments.
            Please respond to this letter by amending your registration statement and providing
the requested information. If you do not believe a comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
            After reviewing any amendment to your registration statement and the information
you provide in response to this letter, we may have additional comments.
Form F-1 filed September 16, 2024
General
1.In light of the six-month suspension of your auditor, PricewaterhouseCoopers Zhong
Tian LLP ("PwC China"), by applicable Chinese authorities , please tell us how it may
impact your filing and your plans moving forward in light of any developments,
including whether the company is planning to continue using the audited financial
statements and consent currently included in the registration statement, or what
alternative plans are being made. For example, it is unclear what alternative plans are
being considered and whether they may require authorization by the CSRC. Please
continue to update us as applicable.

October 21, 2024
Page 2
Risk Factors, page 29
2.We note your disclosure on page 46 related to risks stemming from service providers
that may be subject to regulatory penalties or suspension or found in violation of any
applicable rules and regulations. Please add a separately captioned risk factor
discussing the fact that China's finance ministry and securities regulator recently
imposed a six-month suspension on your auditor, PricewaterhouseCoopers Zhong
Tian LLP ("PwC China"). In addition, clarify and discuss the scope of the suspension,
including:
•the specific dates of the suspension;
•if the suspension impacts your ability to consult with the auditor during the six-
month period;
•if the suspension is expected to have any impact on your ability to make timely
Exchange Act filings that require audits, such as your next 20-F;
•whether the suspension is limited to PwC China or also impacts
PricewaterhouseCoopers LLP, the firm listed on the consent filed as exhibit 23.1,
or other affiliated entities, such as PwC Hong Kong;
•whether there is a possibility the duration of the suspension could be extended
beyond six-months or additional suspensions could be imposed on your auditor or
its affiliate entities, and
•other potential consequences of the suspension that are reasonably likely to have a
material, adverse impact on you.
Description of Share Capital, page 202
3.We note that you removed disclosure related to an exclusive forum provision from
this section, while retaining bracketed disclosure about the risks stemming from the
deposit agreement, including an exclusive forum provision beginning on page 86.
Please provide disclosure about any exclusive forum provisions in your governing
documents here or in another appropriate section. Please ensure that such disclosure
clarifies whether the provision applies to actions arising under the Securities Act or
Exchange Act. If so, please also state that there is uncertainty as to whether a court
would enforce such provision. If the provision applies to Securities Act claims, please
also state that investors cannot waive compliance with the federal securities laws and
the rules and regulations thereunder. In that regard, we note that Section 22 of the
Securities Act creates concurrent jurisdiction for federal and state courts over all suits
brought to enforce any duty or liability created by the Securities Act or the rules and
regulations thereunder. If this provision does not apply to actions arising under the
Securities Act or Exchange Act, please also ensure that the exclusive forum provision
in the governing documents states this clearly, or tell us how you will inform investors
in future filings that the provision does not apply to any actions arising under the
Securities Act or Exchange Act.
Experts, page 246
We note the recent six-month business suspension imposed on your auditor,
PricewaterhouseCoopers Zhong Tian LLP, by the Ministry of Finance in China. 4.

October 21, 2024
Page 3
Please provide us with an analysis explaining how this suspension impacts your
auditor’s ability to provide an updated consent signed by PricewaterhouseCoopers
Zhong Tian LLP or their ability to perform any other auditor-related work in
connection with this registration statement during the period of suspension.
Exhibit Index
Exhibit 23.1, page II-4
5.We note your disclosure on page 246 that the financial statements included in the
Prospectus have been so included in reliance on the report of PricewaterhouseCoopers
Zhong Tian LLP, an independent registered public accounting firm, given the
authority of said firm as experts in auditing and accounting. We also note that the
audit report on page F-2 is signed by PricewaterhouseCoopers Zhong Tian LLP and
that the exhibit index on page II-4 indicates the consent is provided by this same
accounting firm. However, the consent filed as exhibit 23.1 is signed by
PricewaterhouseCoopers LLP. Please explain the relationship between these two
entities and how you determined it was appropriate for PricewaterhouseCoopers LLP
to consent to a report that was issued by PricewaterhouseCoopers Zhong Tian LLP.
6.We note that the consent filed as exhibit 23.1 is signed by PricewaterhouseCoopers
LLP located in Beijing, the People’s Republic of China. According to the PCAOB’s
list of registered accounting firms, we were unable to identify a firm with this name at
this location. Please explain this apparent inconsistency and revise as necessary.
            We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence
of action by the staff.
            Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate
time for us to review any amendment prior to the requested effective date of the registration
statement.
            Please contact Ben Phippen at 202-551-3697 or Marc Thomas at 202-551-3452 if you
have questions regarding comments on the financial statements and related matters. Please
contact John Stickel at 202-551-3324 or Susan Block at 202-551-3210 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Finance